Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment

Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease of the central nervous system. Natalizumab, a humanized anti-α4 integrin monoclonal antibody, is a highly effective treatment approved for MS. An association between MS and an exposure to Epstein-Barr Virus (EBV) sustained by the l...

Descripción completa

Detalles Bibliográficos
Autores principales: Castellazzi, Massimiliano, Delbue, Serena, Elia, Francesca, Gastaldi, Matteo, Franciotta, Diego, Rizzo, Roberta, Bellini, Tiziana, Bergamaschi, Roberto, Granieri, Enrico, Fainardi, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460255/
https://www.ncbi.nlm.nih.gov/pubmed/26101453
http://dx.doi.org/10.1155/2015/901312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460255/
https://www.ncbi.nlm.nih.gov/pubmed/26101453
http://dx.doi.org/10.1155/2015/901312

Ejemplares similares